Global Wellness Strategies Shanti Therapeutics Updates and Symbol Change to GWS

The Shanti Therapeutics Focus on Chronic Pain Market with Psychedelics

Global Wellness Strategies Inc. (CSE: LOAN) (FSE: O3X4) (OTCQB: PNNRF) (formerly Redfund Capital Corp.) ("Global" or the "Company") changes symbol to GWS and introduces Dr. Sud Agarwal BSc, MB ChB, FANZCA, the Chairman of Cannvalate Pty Ltd. and Shanti Therapeutics. His experience and expertise in the psychedelic industry will contribute significantly to our efforts in the space moving forward.

GWS Symbol Change:

Global Wellness Strategies Inc. "Helping you Get Well Soon" is changing its ticker symbol from "LOAN" to "GWS". The Company expects the symbol change to take effect on Wednesday October 6, 2021. The change in the ticker symbol is being made to provide greater visibility with respect to the long-term strategy of the Company: providing high growth companies with financial, operational, and management assistance in the fast-growing market for global wellness. No action is required by existing shareholders with regards to the ticker symbol change.

"We are looking forward to trading under the new 'GWS' symbol on the Canadian Stock Exchange," said Meris Kott, CEO of Global Wellness Strategies. "The new symbol directly aligns with the vision of the Company and the path we foresee taking in order to continue adding significant value to our shareholders by developing and commercializing medicines with our portfolio clients."

Pain & Psychedelics:

While there has been increasing hype and capital markets interest in and research on the use of psychedelics, such as psilocybin, ketamine, LSD and MDMA (aka, ecstasy or molly), for depression, anxiety, PTSD, and other psychiatric disorders, little research has been conducted to date on the use of psychedelics for chronic pain. It is the goal of the Company to be the market leader in the management of pain with IND application to the FDA for a novel drug culminating with clinical trials and changing the landscape with new solutions to solve the pain epidemic.

Additionally, because of the urgent need for improved pharmacological approaches for the treatment of peri-operative pain, Shanti Therapeutics has already filed a patent application outlining a method for the treatment/prevention of pain, the method comprising oral administration of an effective dose of 3,4-methylenedioxymethamphetamine (MDMA).

Meet the founder of Shanti Therapeutics Pty Ltd.:

Dr. Sud Agarwal is a founder and Chairman of Cannvalate Pty Ltd. based in Australia and the co-founder of Shanti Therapeutics Pty Ltd. Sud is a pioneer and a global first-mover in the novel cannabinoid space, a medical research key opinion leader and an experienced listed company executive with deep investment networks. He is also a board member and executive of a number of listed and unlisted companies.

Additionally, Dr. Agarwal is a board certified, specialist anesthesiologist with extensive research credentials in novel drug development and FDA registration. He is the primary inventor of > 20 novel cannabinoid and entheogen patents for a variety of medical illnesses.

"We are honored to work closely with Sud as a team leader at Shanti, and we look forward to his invaluable strategic advice as we continue to grow Global Wellness and enter the psychedelic industry through our definitive acquisition with Cannvalate of their subsidiary Shanti Therapeutics," remarked Global Wellness Strategies CEO, Meris Kott.

About Global Wellness Strategies

Global Wellness Strategies is a prospect generator that provides high growth companies with financial, operational, and management assistance in the fast-growing market for wellness consumer products. The focus of the Company is on global wellness, psychedelics, mycology, hemp and CBD, healthcare-related target companies.

For further information visit websites:
www.globalwellnessstrategies.com and www.shantitherapeutics.com

Or Contact Meris Kott CEO 604.484.0355 or email to info@globalwellnessstrategies.com

Further information about the Company is available on www.SEDAR.com under the Company's profile.

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. Certain statements contained in this release may constitute "forward-looking statements" or "forward-looking information" (collectively "forward-looking information") as those terms are used in the Private Securities Litigation Reform Act of 1995 and similar Canadian laws. These statements relate to future events or future performance. The use of any of the words "could", "intend", "expect", "believe", "will", "projected", "estimated", "anticipates" and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Company's current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. In particular, this release contains forward-looking information relating to the business of the Company, its financing and certain corporate changes. The forward-looking information contained in this release is made as of the date hereof and the Company is not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward-looking information. The foregoing statements expressly qualify any forward-looking information contained herein.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/98417

News Provided by Newsfile via QuoteMedia

The Conversation (0)

Trulieve to Open Medical Cannabis Dispensary in Tampa, Florida

New Hillsborough County location will host grand opening celebration Friday December 13

Trulieve Cannabis Corp. (CSE: TRUL ) (OTCQX: TCNNF ) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced the opening of a new medical cannabis dispensary in Tampa, Florida .

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less
Cannabis leaves, US flag.

Cannabis Round-Up: DEA Postpones Rescheduling Hearing, Key Players Share Quarterly Results

November was a busy month for the cannabis industry, with a slew of US-centric developments.

A hearing on cannabis rescheduling was postponed until 2025, although the incoming Trump administration has signaled its intent to follow through on the change despite opposition from some Republican lawmakers.

Meanwhile, several states voted on cannabis measures, and companies reported their latest quarterly results.

Keep reading...Show less
Cannabis plants and a stock chart.

US Cannabis Sales Hit Record in October, Market Set to Reach US$55 Billion by 2030

Cannabis sales in the US reached a record high in October, with retail transactions totaling approximately US$2.8 billion, according to data from LeafLink, a wholesale cannabis platform.

While sales saw a slight 2.1 percent dip compared to September, they were up 6.2 percent year-on-year. Total retail cannabis sales in 2024 are expected to hit US$32.6 billion, representing a 10.8 percent increase over the previous year.

LeafLink attributes much of this growth to new licenses in states such as New York, New Jersey and Ohio.

Keep reading...Show less
Australia flag and cannabis.

Australian Senate Rejects Greens' Bill to Legalise Cannabis

The Australian Greens announced on Wednesday, November 27, that the Legalising Cannabis Bill 2023 was defeated in a 13 to 24 vote, preventing the federal legalisation of cannabis.

“The Labor and Coalition parties joined together to try and hold Australia back in the 1950s by blocking this desperately needed reform,” said Greens Senator for New South Wales David Shoebridge.

Shoebridge said on X that the parties “teamed up” to vote against legalizing cannabis in the Senate, “yet another example of the major parties working together to refuse any sort of progress.”

All 11 Greens Senators voted in favour of the Bill, as did Independent Senators Lidia Thorpe and Tammy Tyrrell.

Keep reading...Show less
Cannabis and Australian money.

Victoria Amends Driving Rules for Medicinal Cannabis Users, Changes Effective in Mid-2025

Both houses of parliament in Victoria, Australia, have successfully passed the Roads and Road Safety Legislation Amendment Bill 2024, Cannabis Council Australia said in a recent newsletter.

The organisation sees this as a “promising development” in the area, calling it a “critical legislative milestone." The bill's passing will allow for judicial discretion when decisions about medicinal cannabis are made.

Magistrates will now have the ability to evaluate individual cases where drivers who hold valid medicinal cannabis prescriptions test positive for THC, but show no signs of impairment.

Keep reading...Show less

Trulieve to Open Medical Cannabis Dispensary in Jacksonville, Florida

New Duval County location will host grand opening celebration Friday, December 6 th

Trulieve Cannabis Corp. (CSE: TRUL ) (OTCQX: TCNNF ) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., announced the opening of a new medical cannabis dispensary in Jacksonville, Florida on Saturday, November 23 .

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

×